Perfusion imaging with computed tomography: brain and beyond

The availability of rapid imaging with multidetector CT systems and commercial analysis software has made perfusion imaging with CT an everyday technique, not only for the brain but also for other body organs. Perfusion imaging is usually performed as an adjunct to a conventional CT examination and is therefore particularly appropriate when a conventional CT is part of routine clinical protocols. The derived values are reproducible and have been validated against a range of reference techniques. Within neuroradiology, perfusion CT has attracted interest in the assessment of acute stroke but can also be used to assess secondary injury in head trauma and as an adjunct to CT angiography to evaluate cerebral spasm in subarachnoid haemorrhage. Within oncology, perfusion CT provides an imaging correlate for tumour vascularity that can be used to discriminate benign and malignant lesions, as an indicator of tumour aggressiveness, to reveal occult tumour and improve the delineation of tumours during radiotherapy planning, and as a functional assessment of tumour response to therapy. By exploiting the ability of CT systems to quantify contrast enhancement, CT perfusion imaging uses contrast media to assess vascular physiology and so improve diagnosis, prognosis, treatment selection and therapy monitoring.

[1]  K. Ohtomo,et al.  FDG-PET after radiotherapy is a good prognostic indicator of rectal cancer , 2002, Annals of nuclear medicine.

[2]  A. Lammertsma,et al.  Measurement of perfusion in stage IIIA-N2 non-small cell lung cancer using H(2)(15)O and positron emission tomography. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[3]  N. Hattori,et al.  Tumor Blood Flow Measured Using Dynamic Computed Tomography , 1994, Investigative radiology.

[4]  S. Libutti,et al.  Using positron emission tomography 2-deoxy-2-[18F]fluoro-D-glucose, 11CO, and 15O-water for monitoring androgen independent prostate cancer. , 2003, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.

[5]  Jean-Philippe Thiran,et al.  Prognostic accuracy of cerebral blood flow measurement by perfusion computed tomography, at the time of emergency room admission, in acute stroke patients , 2002, Annals of neurology.

[6]  J. Jinkins,et al.  The characteristics of cerebral meningiomas and surrounding tissues on dynamic CT , 2004, Neuroradiology.

[7]  R. Meuli,et al.  Admission perfusion CT: prognostic value in patients with severe head trauma. , 2004, Radiology.

[8]  Ricky T. Tong,et al.  Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer , 2004, Nature Medicine.

[9]  Ting-Yim Lee,et al.  Correlation of early dynamic CT perfusion imaging with whole-brain MR diffusion and perfusion imaging in acute hemispheric stroke. , 2003, AJNR. American journal of neuroradiology.

[10]  T. Purdie,et al.  Functional CT imaging of angiogenesis in rabbit VX2 soft-tissue tumour. , 2001, Physics in medicine and biology.

[11]  G Brix,et al.  Tumor microcirculation evaluated by dynamic magnetic resonance imaging predicts therapy outcome for primary rectal carcinoma. , 2001, Cancer research.

[12]  B. Rosen,et al.  High microvascular blood volume is associated with high glucose uptake and tumor angiogenesis in human gliomas. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[13]  K. Miles,et al.  Blood flow–metabolic relationships are dependent on tumour size in non-small cell lung cancer: a study using quantitative contrast-enhanced computer tomography and positron emission tomography , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[14]  N. Müller,et al.  Lung nodule enhancement at CT: multicenter study. , 2000, Radiology.

[15]  K. Miles,et al.  Perfusion CT for the assessment of tumour vascularity: which protocol? , 2003, The British journal of radiology.

[16]  J D Pickard,et al.  Reproducibility of quantitative CT perfusion imaging. , 2001, The British journal of radiology.

[17]  L. Axel Cerebral blood flow determination by rapid-sequence computed tomography: theoretical analysis. , 1980, Radiology.

[18]  Robert B Livingston,et al.  Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[19]  Robert B Livingston,et al.  Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  Mohamed Allaoua,et al.  Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose. , 2004, International journal of radiation oncology, biology, physics.

[21]  M. P. Hayball,et al.  Assessment of quantitative computed tomographic cerebral perfusion imaging with H2150 positron emission tomography , 2000, Neurological research.

[22]  J. Thiran,et al.  Comparison of Admission Perfusion Computed Tomography and Qualitative Diffusion- and Perfusion-Weighted Magnetic Resonance Imaging in Acute Stroke Patients , 2002, Stroke.

[23]  R. Craen,et al.  Monitoring cerebral perfusion after subarachnoid hemorrhage using CT , 2001, Neuroradiology.

[24]  K. Miles,et al.  Functional computed tomography in oncology. , 2002, European journal of cancer.

[25]  R. Gillies,et al.  Microenvironmental and cellular consequences of altered blood flow in tumours. , 2003, The British journal of radiology.

[26]  M. Wiesmann,et al.  Dynamic CT perfusion imaging of acute stroke. , 2000, AJNR. American journal of neuroradiology.

[27]  Thomas Beyer,et al.  To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CT. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[28]  F. Fazio,et al.  Fluoro-deoxi-glucose uptake and angiogenesis are independent biological features in lung metastases , 2002, British Journal of Cancer.

[29]  K. Miles Brain perfusion: computed tomography applications , 2004, Neuroradiology.

[30]  R. Craen,et al.  A CT method to measure hemodynamics in brain tumors: validation and application of cerebral blood flow maps. , 2000, AJNR. American journal of neuroradiology.

[31]  J. Thiran,et al.  Simultaneous measurement of regional cerebral blood flow by perfusion CT and stable xenon CT: a validation study. , 2001, AJNR. American journal of neuroradiology.

[32]  K. Miles,et al.  Hepatic metastases: the value of quantitative assessment of contrast enhancement on computed tomography. , 1999, European journal of radiology.

[33]  L. Ellis,et al.  Development of biologic markers of response and assessment of antiangiogenic activity in a clinical trial of human recombinant endostatin. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.